Are Pharmaceuticals with Evolutionary Conserved Molecular Drug Targets More Potent to Cause Toxic Effects in Non-Target Organisms?

Open Access

Peer-reviewed

Research Article

Sara Furuhagen ,

* E-mail: sara.furuhagen@itm.su.se

Affiliation Department of Applied Environmental Science, Stockholm University, Stockholm, Sweden
⨯
Anne Fuchs,

Affiliation Department of Applied Environmental Science, Stockholm University, Stockholm, Sweden
⨯
Elin Lundström Belleza,

Affiliation Department of Applied Environmental Science, Stockholm University, Stockholm, Sweden
⨯
Magnus Breitholtz,

Affiliation Department of Applied Environmental Science, Stockholm University, Stockholm, Sweden
⨯
Elena Gorokhova

Affiliation Department of Applied Environmental Science, Stockholm University, Stockholm, Sweden
⨯

Reader Comments (0)

Drug discovery
Is the Subject Area "Drug discovery" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Protein synthesis
Is the Subject Area "Protein synthesis" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Daphnia
Is the Subject Area "Daphnia" applicable to this article?

Thanks for your feedback.
Fish physiology
Is the Subject Area "Fish physiology" applicable to this article?

Thanks for your feedback.
Invertebrates
Is the Subject Area "Invertebrates" applicable to this article?

Thanks for your feedback.
Algae
Is the Subject Area "Algae" applicable to this article?

Thanks for your feedback.